Prediseases: Who benefits from treating prehypertension?

Research output: Contribution to journalArticleProfessional

3 Citations (Scopus)

Abstract

With a drug company funded conference on prehypertension set to take place next year, Ray Moynihan examines the emergence of this controversial new classification
Original languageEnglish
Pages (from-to)484-485
Number of pages4
JournalBMJ (Online)
Volume341
Issue number7771
DOIs
Publication statusPublished - 4 Sept 2010

Fingerprint

Dive into the research topics of 'Prediseases: Who benefits from treating prehypertension?'. Together they form a unique fingerprint.

Cite this